Cargando…

P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.

Detalles Bibliográficos
Autores principales: Michalka, Jozef, Marková, Jana, Gahérová, Ľubica, Maco, Mária, Procházka, Vít, Kořen, Jan, Sýkorová, Alice, Štěpánková, Pavla, Steinerová, Kateřina, Mohammad, Lekaa, Ďuraš, Juraj, Velacková, Barbora, Doležal, Tomáš, Benešová, Kateřina, Lukášová, Marie, Janíková, Andrea, Král., Zdeněk., Móciková, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621554/
http://dx.doi.org/10.1097/01.HS9.0000890984.54786.aa
_version_ 1784821584208330752
author Michalka, Jozef
Marková, Jana
Gahérová, Ľubica
Maco, Mária
Procházka, Vít
Kořen, Jan
Sýkorová, Alice
Štěpánková, Pavla
Steinerová, Kateřina
Mohammad, Lekaa
Ďuraš, Juraj
Velacková, Barbora
Doležal, Tomáš
Benešová, Kateřina
Lukášová, Marie
Janíková, Andrea
Král., Zdeněk.
Móciková, Heidi
author_facet Michalka, Jozef
Marková, Jana
Gahérová, Ľubica
Maco, Mária
Procházka, Vít
Kořen, Jan
Sýkorová, Alice
Štěpánková, Pavla
Steinerová, Kateřina
Mohammad, Lekaa
Ďuraš, Juraj
Velacková, Barbora
Doležal, Tomáš
Benešová, Kateřina
Lukášová, Marie
Janíková, Andrea
Král., Zdeněk.
Móciková, Heidi
author_sort Michalka, Jozef
collection PubMed
description
format Online
Article
Text
id pubmed-9621554
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96215542022-11-01 P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic. Michalka, Jozef Marková, Jana Gahérová, Ľubica Maco, Mária Procházka, Vít Kořen, Jan Sýkorová, Alice Štěpánková, Pavla Steinerová, Kateřina Mohammad, Lekaa Ďuraš, Juraj Velacková, Barbora Doležal, Tomáš Benešová, Kateřina Lukášová, Marie Janíková, Andrea Král., Zdeněk. Móciková, Heidi Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621554/ http://dx.doi.org/10.1097/01.HS9.0000890984.54786.aa Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Relapsed/Refractory
Michalka, Jozef
Marková, Jana
Gahérová, Ľubica
Maco, Mária
Procházka, Vít
Kořen, Jan
Sýkorová, Alice
Štěpánková, Pavla
Steinerová, Kateřina
Mohammad, Lekaa
Ďuraš, Juraj
Velacková, Barbora
Doležal, Tomáš
Benešová, Kateřina
Lukášová, Marie
Janíková, Andrea
Král., Zdeněk.
Móciková, Heidi
P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
title P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
title_full P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
title_fullStr P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
title_full_unstemmed P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
title_short P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
title_sort p104: consolidation therapy with brentuximab vedotin after autologous stem cell transplantation for relapsed/refractory hodgkin lymphoma in the czech republic.
topic Relapsed/Refractory
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621554/
http://dx.doi.org/10.1097/01.HS9.0000890984.54786.aa
work_keys_str_mv AT michalkajozef p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT markovajana p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT gaherovalubica p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT macomaria p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT prochazkavit p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT korenjan p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT sykorovaalice p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT stepankovapavla p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT steinerovakaterina p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT mohammadlekaa p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT durasjuraj p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT velackovabarbora p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT dolezaltomas p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT benesovakaterina p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT lukasovamarie p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT janikovaandrea p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT kralzdenek p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic
AT mocikovaheidi p104consolidationtherapywithbrentuximabvedotinafterautologousstemcelltransplantationforrelapsedrefractoryhodgkinlymphomaintheczechrepublic